Nature3 months agoHealthResearchers call for a major rethink of how Alzheimer's treatments are evaluatedLecanemab approved by FDA for Alzheimer's treatment Disease-modifying drugs target root cause and offer cumulative benefits [ more ]
time.com2 weeks agoOMG scienceThe Next Potential Alzheimer's Drug Clears a Big HurdleDrug companies are making progress in Alzheimer's treatment with FDA panel's positive evaluation of Eli Lilly's donanemab. [ more ]